149 results on '"Falaschetti, Emanuela"'
Search Results
2. The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection—study protocol for a two-stage randomised phase II trial
3. Decision support system to evaluate ventilation in the acute respiratory distress syndrome (DeVENT study)—trial protocol
4. Changes in Myocardial Perfusion After Coronary Sinus Reducer Implantation for Refractory Angina – Assessment Using Fully Automated Quantitative Stress Perfusion Cardiac MRI
5. Acute Sheetlet Mobility Predicts Adverse Left Ventricular Remodelling After STEMI
6. Diagnostic Performance of Biphasic Diffusion Tensor Cardiovascular Magnetic Resonance for Detection of Segments with Myocardial Infarction
7. Decision support system to evaluate VENTilation in the Acute Respiratory Distress Syndrome
8. Are valved holding chambers (VHCs) interchangeable? An in vitro evaluation of VHC equivalence
9. Kiosk 10R-TA-03 - Acute Sheetlet Mobility Predicts Adverse Left Ventricular Remodelling After STEMI
10. Kiosk 10R-TA-05 - Diagnostic Performance of Biphasic Diffusion Tensor Cardiovascular Magnetic Resonance for Detection of Segments with Myocardial Infarction
11. CMR 3-81 - Changes in Myocardial Perfusion After Coronary Sinus Reducer Implantation for Refractory Angina – Assessment Using Fully Automated Quantitative Stress Perfusion Cardiac MRI
12. Effects of haemodynamically atrio‐ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure ( HOPE‐HF ) randomized, double‐blind, cross‐over trial
13. Randomized Crossover Trial of the Impact of Morning or Evening Dosing of Antihypertensive Agents on 24-Hour Ambulatory Blood Pressure: The HARMONY Trial
14. Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: a prospective, randomized, multi-centre, open label trial
15. Hypertension management in England: a serial cross-sectional study from 1994 to 2011
16. Association of Retinopathy and Retinal Microvascular Abnormalities With Stroke and Cerebrovascular Disease
17. Comparison of methods for modelling a count outcome with excess zeros: application to Activities of Daily Living (ADL-s)
18. Additional file 4 of The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection—study protocol for a two-stage randomised phase II trial
19. Additional file 3 of The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection—study protocol for a two-stage randomised phase II trial
20. Additional file 2 of The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection—study protocol for a two-stage randomised phase II trial
21. Additional file 1 of The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection—study protocol for a two-stage randomised phase II trial
22. Age Trajectories of Quality of Life among Older Adults: Results from the English Longitudinal Study of Ageing
23. Decision support system to evaluate VENTilation in the Acute Respiratory Distress Syndrome (DeVENT study) – Trial Protocol
24. The RIO Trial: Rationale, Design, And The Role of Community Involvement In A Randomised Placebo-Controlled Trial of Antiretroviral Therapy Plus Dual Long-Acting HIV-Specific Broadly Neutralising Antibodies (bNAbs) In Participants Diagnosed With Recent HIV Infection - Study Protocol For A Two-Stage Randomised Phase II Trial
25. Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity
26. Most older pedestrians are unable to cross the road in time: a cross-sectional study
27. Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey – 2006
28. Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children
29. Determinants of vascular phenotype in a large childhood population: the Avon Longitudinal Study of Parents and Children (ALSPAC)
30. Diagnosis of COPD
31. OVERWEIGHT AND OBESITY PREVALENCE TRENDS BY SOCIAL CLASS AMONG UK CHILDREN
32. Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity
33. Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial:HOPE HF Trial rationale and design
34. Ablation versus Anti-Arrhythmic Therapy for Reducing All Hospital Episodes from Recurrent Atrial Fibrillation (AVATAR-AF): Design and rationale
35. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
36. Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients With Hypertrophic Cardiomyopathy
37. LBOS 01-01A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR ABPM LEVELS
38. An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK)
39. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over
40. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over
41. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study
42. Childhood Obesity and Vascular Phenotypes
43. Adipose and Height Growth Through Childhood and Blood Pressure Status in a Large Prospective Cohort Study
44. Implementation of Pay for Performance Policy in England
45. Continued Improvement in Hypertension Management in England
46. Association Between Smoking and Blood Pressure
47. Influence of hormone replacement therapy on C-reactive protein population-based data
48. Birthweight and blood pressure in children: Does the association exists?
49. Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance.
50. Predictors of the efficacy of His bundle pacing in patients with a prolonged PR interval: A stratified analysis of the HOPE-HF randomized controlled trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.